2 completed. 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 2 |
Follow Transplantation, Stem Cell: new trials by email Literature Review of Transplantation, Stem Cell trials Research Report on Transplantation, Stem Cell
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study in Healthy Volunteers, to Evaluate the Safety, Efficacy and Dose Responses of SB-751689 (Ronacaleret) Ronacaleret 100 mg, Ronacaleret 400 mg, Plerixafor - Transplantation, Stem Cell | Phase 1 | Completed | GlaxoSmithKline | 24 | 2012-11-02 | 2017-06-07 |
| Immunotherapy With NK Cell, Rituximab and Rhu-GMCSF in Non-Myeloablative Allogeneic Stem Cell Transplantation GM-CSF, Rituximab, NK Cell Infusion - Lymphoma, Leukemia | Phase 1 | Completed | M.D. Anderson Cancer Center | 6 | 2006-09-01 | 2019-07-31 |
Leukemia (1) · Leukemia, Lymphocytic, Chronic, B-Cell (1) · Lymphoma (1) · Lymphoma, B-Cell (1) · Lymphoma, Non-Hodgkin (1)
Chronic Disease (1) · Disease Attributes (1) · Hematologic Diseases (1) · Hemic and Lymphatic Diseases (1) · Immune System Diseases (1) · Immunoproliferative Disorders (1) · Leukemia, B-Cell (1) · Leukemia, Lymphoid (1) · Lymphatic Diseases (1) · Lymphoproliferative Disorders (1) · Neoplasms (1) · Neoplasms by Histologic Type (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1)
Granulocyte-Macrophage Colony-Stimulating Factor (1) · Rituximab (1) · plerixafor (1) · ronacaleret (1) · sargramostim (1)
GlaxoSmithKline (1) · M.D. Anderson Cancer Center (1)
United States (2)